Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab

Author(s):
Heijde, D. van der; Gladman, D.D.; FitzGerald, O.; Kavanaugh, A.; Graham, D.; Wang, C.S.; Fallon, L.
Published
2019
Publication type
Article / Letter to editor
C-REACTIVE PROTEINPREDICTORSPSORIATIC ARTHRITISRADIOGRAPHIC PROGRESSIONSTRUCTURAL PROGRESSIONTOFACITINIB
Date issued
2019-09-01
Language
English
Is part of
Journal of Rheumatology (2019), Vol. 46, no. 9, p. 1089-1096
hdl
1887/120946
doi
10.3899/jrheum.180971